Dihydroxythiobinupharidine

CAS No.
30343-70-5
Chemical Name:
Dihydroxythiobinupharidine
Synonyms
Dihydroxythiobinupharidine;6,6′-Dihydroxythiobinupharidine;6,6'-Dihydroxythiobinupharidine >=95% (HPLC);Dispiro[2H-quinolizine-3(4H),2'(3'H)-thiophene-4'(5'H),3''(4''H)-[2H]quinolizine]-4,4''-diol, 6,6''-di-3-furanyldodecahydro-9,9''-dimethyl-, (2'S,3''S,4S,4''R,6S,6''S,9R,9''R,9aS,9''aS)-
CBNumber:
CB81120248
Molecular Formula:
C30H42N2O4S
Molecular Weight:
526.73
MDL Number:
MFCD30738198
MOL File:
30343-70-5.mol
MSDS File:
SDS
Last updated:2023-04-23 13:52:06

Dihydroxythiobinupharidine Properties

Boiling point 667.3±55.0 °C(Predicted)
Density 1.30±0.1 g/cm3(Predicted)
storage temp. -20°C
form powder
pka 13.42±0.70(Predicted)

Dihydroxythiobinupharidine price More Price(1)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SMB00609 6,6′-Dihydroxythiobinupharidine ≥95% (HPLC) 30343-70-5 1mg $545 2024-03-01 Buy
Product number Packaging Price Buy
SMB00609 1mg $545 Buy

Dihydroxythiobinupharidine Chemical Properties,Uses,Production

General Description

6,6′-Dihydroxythiobinupharidine is an active compound found in Nuphar lutea extract. It is a dimeric sesquiterpene thioalkaloid which presents multiple activities.

Biochem/physiol Actions

6,6′-Dihydroxythiobinupharidine inhibits NFκB activation, leading to an induction of apoptosis via cleavage of procaspase-9 and poly (ADP-ribose) polymerase (PARP). It was also found to act synergistically with cytotoxic drugs such as cisplatin and etoposide, enabling their cytotoxic effect at lower concentrations. 6,6′-Dihydroxythiobinupharidine was found to have cytotoxic activity at a concentration of ~10 μM on human leukemia cells (U937), mouse melanoma cells (B16F10), and human fibroblasts (HT1080).In addition, Nuphar lutea extract was effective against both Leishmania promastigote and amastigote forms (IC50?=?2?±?0.12?μg/mL; ID50?=?0.65?±?0.023?μg/mL; LD50?=?2.1?±?0.096?μg/mL, STI?=?3.23). A synergistic antileishmanial activity was demonstrated with the antileishmanial drug, paromomycin.Recently 6,6′-dihydroxythiobinupharidine was found to be active against MRSA and VRE strains with an MIC of 1-4?μg/mL. Inhibition of DNA topoisomerase?IV but not DNA gyrase in S.?aureus was suggested as the mechanism of action. 6,6′-Dihydroxythiobinupharidine was also shown to promote neutrophil effector bactericidal functions.

Dihydroxythiobinupharidine Preparation Products And Raw materials

Raw materials

Preparation Products

Dihydroxythiobinupharidine Suppliers

Global( 4)Suppliers
Supplier Tel Email Country ProdList Advantage
Sigma-Aldrich 021-61415566 800-8193336 orderCN@merckgroup.com China 51471 80
Energy Chemical 021-58432009 400-005-6266 marketing@energy-chemical.com China 44941 58
Supplier Advantage
Sigma-Aldrich 80
Energy Chemical 58
Dihydroxythiobinupharidine 6,6′-Dihydroxythiobinupharidine Dispiro[2H-quinolizine-3(4H),2'(3'H)-thiophene-4'(5'H),3''(4''H)-[2H]quinolizine]-4,4''-diol, 6,6''-di-3-furanyldodecahydro-9,9''-dimethyl-, (2'S,3''S,4S,4''R,6S,6''S,9R,9''R,9aS,9''aS)- 6,6'-Dihydroxythiobinupharidine >=95% (HPLC) 30343-70-5 C30H42N2O4S